Brokerages Set Novavax, Inc. (NASDAQ:NVAX) Price Target at $19.20
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned an average recommendation of “Hold” from the seven analysts that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. The average […]
